Nodus oncology is developing first and best-in-class molecules inhibiting novel targets within the DNA damage response and replication stress response.
Supported by most recent scientific advances, we are developing the next wave of cancer therapeutics in the DNA damage response (DDR) area.
Founded by Cumulus Oncology and in partnership with the Lead discovery Center, Nodus Oncology is developing an innovative portfolio focused on synthetic lethality and collateral vulnerabilities in molecularly defined cancer patient populations
Company Details
- Employees
- 4
- Founded
- -
- Address
- Alderley Park, Macclesfield,sk10 4tg,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.nodusoncology.com/
- Keywords
- Oncology.
- HQ
- Macclesfield
Nodus Oncology Questions
Nodus Oncology's website is https://www.nodusoncology.com/
Nodus Oncology's LinkedIn profile is https://uk.linkedin.com/company/nodus-oncology
Nodus Oncology has
4 employees.
View email and phone details for 4
employees at Nodus Oncology.
Nodus Oncology's industry is
Biotechnology Research
Nodus Oncology's top competitors are
Charles River Laboratories,
Cumulus Oncology,
Exmoor Pharma,
Nexus Bioquest,
Extracellular,
Epitopea,
Redx Pharma,
Gio Therapeutics,
Leadxpro Ag,
Pencil Biosciences Limited.
Nodus Oncology's categories are Biotechnology Research
Nodus Oncology's founding year is 2022
